Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens
- PMID: 176393
- DOI: 10.1093/jnci/56.3.485
Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens
Abstract
Antibody-dependent lymphocyte cytotoxicity (ADLC) was demonstrated against Epstein-Barr virus (EBV)-infected RAJI cells with peripheral with peripheral blood lymphocytes from EBV-infected donors. No cytotoxic activity was detected against unifected RAJl cells. The results indicated that this antibody-mediated cytotoxic reaction was directed against the same EBV-induced membrane antigens (MA) previously defined by the membrane immunofluorescence (MF) assay. Antibody to EBV-associated early antigens did not participate in this in vitro reaction. Antibody titers to EBV-induced MA were significantly higher by the ADLC assay in comparison with the MF test. A preliminary study showed no relationship between high antibody titers and the presence of EBV-associated malignancies. The possible in vivo significance of this immune reaction was discussed.
Similar articles
-
Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.J Natl Cancer Inst. 1970 Nov;45(5):989-95. J Natl Cancer Inst. 1970. PMID: 18605425
-
Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.J Infect Dis. 1994 Dec;170(6):1439-47. doi: 10.1093/infdis/170.6.1439. J Infect Dis. 1994. PMID: 7995983
-
Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.Int J Cancer. 1974 Oct 15;14(4):530-8. doi: 10.1002/ijc.2910140413. Int J Cancer. 1974. PMID: 4376526 No abstract available.
-
Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.Springer Semin Immunopathol. 1991;13(2):233-47. doi: 10.1007/BF00201471. Springer Semin Immunopathol. 1991. PMID: 1664988 Review. No abstract available.
-
Epstein-barr-virus nuclear antigen.Prog Med Virol. 1982;28:145-79. Prog Med Virol. 1982. PMID: 6283600 Review. No abstract available.
Cited by
-
Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.J Exp Med. 1985 May 1;161(5):1097-111. doi: 10.1084/jem.161.5.1097. J Exp Med. 1985. PMID: 2580934 Free PMC article.
-
Epstein-Barr virus serology in nasopharyngeal carcinomas and other head and neck neoplasms in Italy.J Cancer Res Clin Oncol. 1985;110(2):157-60. doi: 10.1007/BF00402731. J Cancer Res Clin Oncol. 1985. PMID: 2995399 Free PMC article.
-
Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.Clin Exp Immunol. 1977 Jul;29(1):11-5. Clin Exp Immunol. 1977. PMID: 70292 Free PMC article.
-
Scanning and transmission electron microscopy study of antibody-dependent lymphocyte-mediated cytotoxicity on measles virus-infected cells.Infect Immun. 1980 Oct;30(1):303-15. doi: 10.1128/iai.30.1.303-315.1980. Infect Immun. 1980. PMID: 7439976 Free PMC article.
-
Papain solubilization of the Epstein-Barr virus-induced membrane antigen.J Virol. 1978 Oct;28(1):344-51. doi: 10.1128/JVI.28.1.344-351.1978. J Virol. 1978. PMID: 81320 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources